<qa>  What is the name of the subject who has had rSIFN-co administration within1. Subjects who have had chemotherapy or radiotherapy within 4 weeks 6 weeks for nitrosoureas or mitomycin C prior to start of rSIFN-co administration or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier. 